ADMA
NASDAQ · Biotechnology
Adma Biologics Inc
$9.90
-0.16 (-1.59%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-39.19%
1Y
-39.56%
YTD
-44.63%
Open$9.97
Previous Close$10.06
Day High$10.19
Day Low$9.75
52W High$20.46
52W Low$7.21
Volume—
Avg Volume2.68M
Market Cap2.25B
P/E Ratio13.63
EPS$0.68
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$17.86
Below
SMA 200
$17.61
Below
RSI (14)
42.2
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
11 analysts
Price Target
+255.8% upside
Current
$9.90
$9.90
Target
$35.22
$35.22
$21.76
$35.22 avg
$46.82
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 474.12M | 318.12M | 922.90M |
| Net Income | 136.54M | 82.45M | -95,808,796 |
| Profit Margin | 28.8% | 27.4% | -10.4% |
| EBITDA | 174.96M | 111.52M | -107,012,515 |
| Free Cash Flow | — | — | -83,155,340 |
| Rev Growth | +49.0% | +49.0% | +20.1% |
| Debt/Equity | 0.15 | 0.15 | 0.64 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |